Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2025

Conditions

SepsisCritical Illness

Interventions

DRUG

Intravenous DNase I

Dose-escalating intravenous infusion of DNase I

Trial Locations (1)

RECRUITING

Hamilton Health Sciences, Hamilton

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McMaster University

OTHER